I Tabah

786 total citations
10 papers, 523 citations indexed

About

I Tabah is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, I Tabah has authored 10 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 3 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in I Tabah's work include Neutropenia and Cancer Infections (3 papers), Hematological disorders and diagnostics (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). I Tabah is often cited by papers focused on Neutropenia and Cancer Infections (3 papers), Hematological disorders and diagnostics (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). I Tabah collaborates with scholars based in France and Switzerland. I Tabah's co-authors include Hervé Tilly, Pauline Brice, Éric Lepage, Nicole Brousse, Corinne Haïoun, Nicole Straetmans, Philippe Moreau, Y Bastion, Philippe Solal‐Céligny and Henri Roché and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

I Tabah

10 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I Tabah France	6	424	380	154	99	84	10	523
M. Bast United States	8	558 1.3×	347 0.9×	200 1.3×	52 0.5×	135 1.6×	10	609
C. Foussard France	12	375 0.9×	263 0.7×	236 1.5×	54 0.5×	66 0.8×	25	517
JM Vose United States	10	529 1.2×	461 1.2×	199 1.3×	35 0.4×	150 1.8×	13	748
Doreen M. Hallman United States	6	583 1.4×	517 1.4×	308 2.0×	60 0.6×	103 1.2×	8	688
John Apostolidis Greece	13	586 1.4×	473 1.2×	214 1.4×	35 0.4×	122 1.5×	34	810
Warren G. Sanger United States	7	286 0.7×	183 0.5×	150 1.0×	26 0.3×	61 0.7×	9	467
CR Kjeldsberg United States	11	511 1.2×	340 0.9×	229 1.5×	21 0.2×	94 1.1×	23	713
KM Ardeshna United Kingdom	2	336 0.8×	259 0.7×	141 0.9×	70 0.7×	64 0.8×	3	377
Christina Nickenig Germany	11	378 0.9×	272 0.7×	200 1.3×	16 0.2×	89 1.1×	20	569
Suguru Fukuhara Japan	14	433 1.0×	260 0.7×	183 1.2×	27 0.3×	137 1.6×	83	603

Countries citing papers authored by I Tabah

Since Specialization

Citations

This map shows the geographic impact of I Tabah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Tabah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Tabah more than expected).

Fields of papers citing papers by I Tabah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Tabah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Tabah. The network helps show where I Tabah may publish in the future.

Co-authorship network of co-authors of I Tabah

This figure shows the co-authorship network connecting the top 25 collaborators of I Tabah. A scholar is included among the top collaborators of I Tabah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Tabah. I Tabah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Guetz, G. Des, Françoise Montravers, I Tabah, et al.. (2003). Isolated Metastatic Adrenal Involvement with Colon Cancer and FDG Coincidence Detection Imaging. Clinical Nuclear Medicine. 28(3). 238–238. 4 indexed citations

Ravaud, Alain, Christine Chevreau, Laurent Cany, et al.. (1998). Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial.. Journal of Clinical Oncology. 16(9). 2930–2936. 31 indexed citations

Brice, Pauline, Y Bastion, Éric Lepage, et al.. (1997). Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte.. Journal of Clinical Oncology. 15(3). 1110–1117. 446 indexed citations

Colombat, P, Martine Delain, Isabelle Desbois, et al.. (1996). Granulocyte-macrophage colony-stimulating factor accelerates hematopoietic recovery after autologous bone marrow or peripheral blood progenitor cell transplantation and high-dose chemotherapy for lymphoma.. PubMed. 18(2). 293–9. 11 indexed citations

Sévenet, F, et al.. (1996). [Treatment of metastatic carcinoid tumors with interferon-alpha. Five cases].. PubMed. 25(2). 63–7. 4 indexed citations

Troussard, Xavier, Margaret Macro, A.M. Peny, et al.. (1995). Human recombinant granulocyte‐macrophage colony stimulating factor (hrGM‐CSF) improves double hemibody irradiation (DHBI) tolerance in patients with stage III multiple myeloma: A pilot study. British Journal of Haematology. 89(1). 191–195. 9 indexed citations

Négrier, S., A. Mercatello, Yacine Merrouche, et al.. (1995). Intensive Regimen of Cytokines with Interleukin-2 and Interferon Alfa-2B in Selected Patients with Metastatic Renal Carcinoma. Journal of Immunotherapy. 17(1). 62–68. 6 indexed citations

Ravaud, Alain, Christine Chevreau, F. Bonichon, et al.. (1995). 247 A phase III trial of recombinant granulocyte-macrophage colony stimulating factor (GM-CSF) as corrective treatment in patients (PTS) with neutropenic fever following antineoplastic chemotherapy (CT): Results of an intermediate analysis. European Journal of Cancer. 31. S54–S54. 2 indexed citations

Philip, Thierry, Sylvie Négrier, Christine Lasset, et al.. (1993). Patients with metastatic renal carcinoma candidate for immunotherapy with cytokines. Analysis of a single institution study on 181 patients. British Journal of Cancer. 68(5). 1036–1042. 9 indexed citations

10.

Tabah, I, et al.. (1992). The use of GM-CSF as adjunctive therapy in small cell lung cancer. Presentation of the interim analysis of a large phase II trial.. PubMed. 39(9). 960–960. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact